Abstract
Fabry disease is a genetic disorder caused by a deficiency of α-galactosidase A (GLA). In our previous studies, we structurally investigated Fabry disease using a structural analysis system, and revealed that structural changes in GLA are very important for understanding the molecular basis of this disease. To the best of our knowledge, there is no database including the structures of mutant GLAs. Herein, we constructed a database of clinical phenotypes, genotypes and structures of mutant GLAs. This database can be accessed as ‘fabry-database.org’, and is user friendly, being equipped with powerful computational tools. This database will help researchers and clinicians who study Fabry disease.
Similar content being viewed by others
Main
Fabry disease (MIM 3010500) is an X-linked genetic disease resulting from a deficiency of α-galactosidase A (GLA, EC 3.2.1.22), and exhibits a wide clinical spectrum, from the early-onset severe ‘classic’ form to the late-onset mild ‘variant’ one.1 Recently, the results of newborn screening revealed that the incidence of Fabry disease is unexpectedly high,2, 3, 4 and that the genotypes of patients with this disease are quite heterogeneous.5
Previously, we constructed structural models of mutant GLAs resulting from 161 Fabry missense mutations, and examined the correlation between structural changes in GLA and the clinical and biochemical phenotypes of Fabry disease.6 Recently, we conducted further structural investigation on Fabry disease using a structural analysis system and revealed that structural changes in GLA are very important for understanding the molecular basis of this disease.5
To the best of our knowledge, there is no database including the structures of mutant GLAs. In order to help researchers and clinicians who study Fabry disease, we built a database of clinical phenotypes, genotypes and structures of mutant GLAs. This database can be accessed as ‘fabry-database.org’, and is user-friendly, being equipped with powerful computational tools like Jmol, which is an open-source Java viewer for chemical structures in 3D (http://www.jmol.org). The web interface and applications are shown in Supplementary Information S1.
Fabry-database.org contains (i) comprehensive information on GLA mutations, (ii) tools for three-dimensional structure visualization and (iii) tools to search for GLA mutations. A total of 504 unique GLA mutations have been incorporated into the database so far. The GLA mutation statistics and the data structure of fabry-database.org are shown in Table 1 and Supplementary Information S2, respectively.
Several tools have been equipped within the database to enhance its scope. The following are the main web tools integrated into fabry-database.org (Figure 1). A text search tool is provided for searching selected fields of the database. A control table option is incorporated for an intensive search. Using this option, users can search for Fabry mutations that are connected with specific phenotypes. Fabry-database.org allows users to display the three-dimensional structures of molecules using Jmol. Users are provided with many options for visualizing the structures of mutant GLAs. Figure 2 represents the pages concerning the structure of a mutant GLA with the T100R amino-acid substitution, as an example. As a structural change in GLA should be related to genotype expression and the outcome of Fabry disease,5, 6 this database will help researchers and clinicians.
The major limitation for expanding this database is that the information on Fabry mutations is too scattered. A lot of literature search is required to further expand it. In the near future, we are hopeful of expanding the database quantitatively to cover all possible amino-acid mutations. This database will be updated manually as soon as enough data become available.
In conclusion, we constructed fabry-database.org, which is available at http://www.fabry-database.org. To access fabry-database.org, the World Wide Web access is a prerequisite. For using all the features of fabry-database.org optimally, plugging in the JavaScript and Java Runtime Environment must be enabled.
References
Desnick, R. J., Ioannou, Y. A. & Eng, C. M. Alpha-galactosidase A deficiency: Fabry disease, in The Metabolic and Molecular Bases of Inherited Disease 8th edn (eds Scriver, C.R., Beaudet, A.L., Sly, W.S. & Valle, D.) 3733–3774 (McGraw-Hill, New York, NY, 2001).
Spada, M., Pagliardini, S., Yasuda, M., Tukel, T., Thiagarajan, G., Sakuraba, H. et al. High incidence of later-onset Fabry disease revealed by newborn screening. Am. J. Hum. Genet. 79, 31–40 (2006).
Hwu, W. L., Chien, Y. H., Lee, N. C., Chiang, S. C., Dobrovolny, R., Huang, A. C. et al. Newborn screening for Fabry disease in Taiwan reveals a high incidence of the later-onset GLA mutation c.936+919G>A (IVS4+919G>A). Hum. Mutat. 30, 1397–1405 (2009).
Lee, B. H., Heo, S. H., Kim, G.- W., Park, J.- Y., Kim, W.- S., Kang, D H et al. Mutations of the GLA gene in Korean patients with Fabry disease and frequency of the E66Q allele as a functional variant in Korean newborns. J. Hum. Genet. 55, 512–517 (2010).
Sugawara, K., Ohno, K., Saito, S. & Sakuraba, H. Structural characterization of mutant alpha-galactosidases causing Fabry disease. J. Hum. Genet. 53, 812–824 (2008).
Matsuzawa, F., Aikawa, S., Doi, H., Okumiya, T. & Sakuraba, H. Fabry disease: correlation between structural changes in alpha-galactosidase, and clinical and biochemical phenotypes. Hum. Genet. 117, 317–328 (2005).
Acknowledgements
This work was supported by the Japan Society for the Promotion of Science.
Author information
Authors and Affiliations
Corresponding author
Additional information
Supplementary Information accompanies the paper on the Journal of Human Genetics website
Supplementary information
Rights and permissions
About this article
Cite this article
Saito, S., Ohno, K. & Sakuraba, H. Fabry-database.org: database of the clinical phenotypes, genotypes and mutant α-galactosidase A structures in Fabry disease. J Hum Genet 56, 467–468 (2011). https://doi.org/10.1038/jhg.2011.31
Received:
Revised:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1038/jhg.2011.31
Keywords
This article is cited by
-
What should rheumatologists know about Gaucher disease and Fabry disease? Connecting the dots for an overview
Advances in Rheumatology (2024)
-
The Spanish Fabry women study: a retrospective observational study describing the phenotype of females with GLA variants
Orphanet Journal of Rare Diseases (2023)
-
X-chromosome inactivation patterns in females with Fabry disease examined by both ultra-deep RNA sequencing and methylation-dependent assay
Clinical and Experimental Nephrology (2021)
-
Fabry disease screening in high-risk populations in Japan: a nationwide study
Orphanet Journal of Rare Diseases (2020)
-
Metabolomic Discovery of Novel Urinary Galabiosylceramide Analogs as Fabry Disease Biomarkers
Journal of the American Society for Mass Spectrometry (2015)